Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized teicoplanin dosing during CRRT in critically ill infected adults
ChiCTR2000038259Phase 4Recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of teicoplanin in Infection (2 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoints: Trough concentration, Plasma concentration and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
teicoplanin
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR2000038259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038259.